J
Jean-Claude Tabet
Researcher at Pierre-and-Marie-Curie University
Publications - 242
Citations - 6461
Jean-Claude Tabet is an academic researcher from Pierre-and-Marie-Curie University. The author has contributed to research in topics: Mass spectrometry & Ion. The author has an hindex of 42, co-authored 237 publications receiving 6106 citations. Previous affiliations of Jean-Claude Tabet include Paris Universitas & Centre national de la recherche scientifique.
Papers
More filters
Journal ArticleDOI
Mass spectrometry for the identification of the discriminating signals from metabolomics: Current status and future trends
Erwan Werner,Jean-François Heilier,Jean-François Heilier,Céline Ducruix,Eric Ezan,Christophe Junot,Jean-Claude Tabet +6 more
TL;DR: This review deals with strengths, limitations and future trends in the identification of signals highlighted by API-MS-based metabolomics, covering the identification process from the determination of the molecular mass and/or its elemental composition to the confirmation of structural hypotheses.
Journal ArticleDOI
Solid Ionic Matrixes for Direct Tissue Analysis and MALDI Imaging
TL;DR: New technical developments for the direct tissue analysis of peptides with ionic liquid made of matrix mixtures and a new outlook on peptide tissue profiling by MS, characterization of compounds from tissue slices, and MALDI-MS high-quality imaging are presented.
Journal ArticleDOI
Modifications of milk constituents during processing: A preliminary benchmarking study
Françis Fenaille,Véronique Parisod,Piero Visani,Sébastien Populaire,Jean-Claude Tabet,Philippe A. Guy +5 more
TL;DR: In this article, protein and lipid modifications of several infant formulas, as well as pasteurized and UHT milk samples were evaluated, and the levels of secondary lipid oxidation products (malondialdehyde and hexanal), proteins modified by early (furosine, measurement of protein glycation) and advanced (carboxymethyllysine) Maillard reactions, and oxidized and crosslinked proteins (protein carbonyls, dityrosine, lysinoalanine) were measured.
Journal ArticleDOI
Immunopurification and mass spectrometric quantification of the active form of a chimeric therapeutic antibody in human serum.
Mathieu Dubois,François Fenaille,Gilles Clément,Martin Lechmann,Jean-Claude Tabet,Eric Ezan,François Becher +6 more
TL;DR: Liquid chromatography coupled with tandem mass spectrometry provides a sensitive, specific, and accurate absolute quantification of Erbitux, a human:murine chimeric mAb used for the treatment of colorectal cancer and is a potential alternative for pharmacokinetic evaluation of mAbs during clinical development.
Journal ArticleDOI
Siderophore peptide, a new type of post-translationally modified antibacterial peptide with potent activity.
Xavier Thomas,Delphine Destoumieux-Garzón,Jean Peduzzi,Carlos Afonso,Alain Blond,Nicolas Birlirakis,Christophe Goulard,Lionel Dubost,Robert Thai,Jean-Claude Tabet,Sylvie Rebuffat +10 more
TL;DR: MccE492m is the first member of a new class of antimicrobial peptides carrying a siderophore-like post-translational modification and showing potent activity, which the authors term siderophile-peptides.